<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate <z:chebi fb="27" ids="27300">vitamin D</z:chebi> as a predictor of <z:hpo ids='HP_0000001'>all</z:hpo>-cause and cardiovascular mortality and risk of progression to micro- or macroalbuminuria in type 2 diabetic patients </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: In a longitudinal observational follow-up study, 289 type 2 diabetic patients with normoalbuminuria (n = 172), <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (n = 73), and macroalbuminuria (n = 44) at baseline were followed for a median (range) of 15.0 (0.2-23) years </plain></SENT>
<SENT sid="2" pm="."><plain>Mean ± SD age was 54 ± 9 years </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma 25-hydroxyvitamin D(3) levels were determined by high-performance liquid chromatography/tandem mass spectrometry on baseline samples </plain></SENT>
<SENT sid="4" pm="."><plain>Severe <z:hpo ids='HP_0100512'>vitamin D deficiency</z:hpo> was defined as the lower 10th percentile (&lt;13.9 nmol/l) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Median (range) <z:chebi fb="27" ids="27300">vitamin D</z:chebi> level was 35.7 (5-136.7) nmol/l </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="27" ids="27300">Vitamin D</z:chebi> levels were not associated with age, sex, estimated glomerular filtration rate, urinary albumin excretion rate (UAER), or A1C at baseline, but low levels were weakly associated with <z:hpo ids='HP_0004421'>elevated systolic blood pressure</z:hpo> (R = 0.13, P = 0.03) </plain></SENT>
<SENT sid="7" pm="."><plain>During follow-up, 196 (68%) patients died </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo>-cause mortality was increased in patients with severe <z:hpo ids='HP_0100512'>vitamin D deficiency</z:hpo> (hazard ratio 1.96 [95% CI 1.29-2.98]) </plain></SENT>
<SENT sid="9" pm="."><plain>The association persisted after adjustment for UAER, A1C, <z:mp ids='MP_0002055'>diabetes</z:mp> duration, and conventional <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> (2.03 [1.31-3.13]) </plain></SENT>
<SENT sid="10" pm="."><plain>Severe <z:hpo ids='HP_0100512'>vitamin D deficiency</z:hpo> was associated with increased cardiovascular mortality (1.95 [1.11-3.44]), and the association persisted after adjustment (1.90 [1.15-3.10]) </plain></SENT>
<SENT sid="11" pm="."><plain>Severe <z:hpo ids='HP_0100512'>vitamin D deficiency</z:hpo> at baseline did not predict progression to micro- or macroalbuminuria </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: In type 2 diabetic patients, severe <z:hpo ids='HP_0100512'>vitamin D deficiency</z:hpo> predicts increased risk of <z:hpo ids='HP_0000001'>all</z:hpo>-cause and cardiovascular mortality, independent of UAER and conventional <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Whether <z:chebi fb="27" ids="27300">vitamin D</z:chebi> substitution improves prognosis remains to be investigated </plain></SENT>
</text></document>